Hormone replacement therapy and cardioprotection in the elderly.
作者信息
Pines A, Kessel H, Mijatovic V, van der Mooren M J
机构信息
Department of Medicine T, Tel-Aviv Sourasky Medical Center, Israel.
出版信息
J R Soc Med. 1998 Sep;91(9):475-8. doi: 10.1177/014107689809100906.
Abstract
摘要
相似文献
1
Hormone replacement therapy and cardioprotection in the elderly.老年人的激素替代疗法与心脏保护作用
J R Soc Med. 1998 Sep;91(9):475-8. doi: 10.1177/014107689809100906.
2
[Difficult decisions on estrogen treatment of women with coronary diseases].[关于冠心病女性雌激素治疗的艰难决策]
Lakartidningen. 1999 May 5;96(18):2196.
3
Coronary heart disease in women--an ounce of prevention.
N Engl J Med. 2000 Aug 24;343(8):572-4. doi: 10.1056/NEJM200008243430809.
4
[Postmenopausal hormone therapy].绝经后激素治疗
Duodecim. 2006;122(5):529-32.
5
Hormone replacement therapy - where to from here? (with response from Sandra Coney).激素替代疗法——何去何从？（附桑德拉·科尼的回应）
N Z Med J. 2002 Sep 13;115(1161):U163; discussion U163.
6
Selective estrogen receptor modulators in coronary artery disease--are they here to stay?冠状动脉疾病中的选择性雌激素受体调节剂——它们会持续存在吗？
Indian Heart J. 2000 Jul-Aug;52(4):487-90.
7
Hormone replacement therapy for secondary prevention of coronary heart disease.激素替代疗法用于冠心病的二级预防。
JAMA. 1999 Mar 3;281(9):794-5; author reply 796-7.
8
Hormone replacement therapy for secondary prevention of coronary heart disease.激素替代疗法用于冠心病的二级预防。
JAMA. 1999 Mar 3;281(9):796; author reply 797.
9
Hormone replacement therapy for secondary prevention of coronary heart disease.激素替代疗法用于冠心病的二级预防。
JAMA. 1999 Mar 3;281(9):795-6; author reply 796-7.
10
Hormone replacement therapy for secondary prevention of coronary heart disease.激素替代疗法用于冠心病的二级预防。
JAMA. 1999 Mar 3;281(9):795; author reply 796-7.
本文引用的文献
1
Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.女性心血管疾病：美国心脏协会写给医疗保健专业人员的声明。写作组
Circulation. 1997 Oct 7;96(7):2468-82. doi: 10.1161/01.cir.96.7.2468.
2
Gender difference in improvement of endothelium-dependent vasodilation after estrogen supplementation.雌激素补充后内皮依赖性血管舒张改善的性别差异。
J Am Coll Cardiol. 1997 Oct;30(4):914-9. doi: 10.1016/s0735-1097(97)00234-9.
3
Myocardial infarction and the use of estrogen and estrogen-progestogen in postmenopausal women.心肌梗死以及绝经后女性中雌激素和雌激素 - 孕激素的使用
Ann Intern Med. 1997 Oct 1;127(7):501-8. doi: 10.7326/0003-4819-127-7-199710010-00001.
4
Hemodynamic effects of transdermal estradiol alone and combined with norethisterone acetate.
Maturitas. 1997 Jun;27(2):163-9. doi: 10.1016/s0378-5122(97)00030-3.
5
Hormone replacement therapy and cardioprotection: basic concepts and clinical considerations.激素替代疗法与心脏保护：基本概念与临床考量
Eur J Obstet Gynecol Reprod Biol. 1997 Feb;71(2):193-7. doi: 10.1016/s0301-2115(96)02634-6.
6
Effect on survival of estrogen replacement therapy after coronary artery bypass grafting.冠状动脉搭桥术后雌激素替代疗法对生存率的影响。
Am J Cardiol. 1997 Apr 1;79(7):847-50. doi: 10.1016/s0002-9149(97)00001-5.
7
Estrogen replacement therapy and prognosis after first myocardial infarction.
Am J Epidemiol. 1997 Feb 1;145(3):269-77. doi: 10.1093/oxfordjournals.aje.a009100.
8
Estrogen replacement therapy after coronary angioplasty in women.
J Am Coll Cardiol. 1997 Jan;29(1):1-5. doi: 10.1016/s0735-1097(96)00443-3.
9
Hormone replacement therapy in the elderly.老年人的激素替代疗法。
Clin Obstet Gynecol. 1996 Dec;39(4):912-32. doi: 10.1097/00003081-199612000-00021.
10
Estrogen, progesterone, and vascular reactivity: potential cellular mechanisms.雌激素、孕酮与血管反应性：潜在的细胞机制
Endocr Rev. 1995 Dec;16(6):739-51. doi: 10.1210/edrv-16-6-739.
Zotero 插件